Fung, E., Patsopoulos, N. A., Belknap, S. M., O’Rourke, D. J., Robb, J. F., Anderson, J. L., . . . Moore, J. H. (2012). Effect of Genetic Variants, Especially CYP2C9 and VKORC1, on the Pharmacology of Warfarin.
Chicago ZitierstilFung, Erik, Nikolaos A. Patsopoulos, Steven M. Belknap, Daniel J. O’Rourke, John F. Robb, Jeffrey L. Anderson, Nicholas W. Shworak, und Jason H. Moore. Effect of Genetic Variants, Especially CYP2C9 and VKORC1, On the Pharmacology of Warfarin. 2012.
MLA ZitierstilFung, Erik, et al. Effect of Genetic Variants, Especially CYP2C9 and VKORC1, On the Pharmacology of Warfarin. 2012.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.